{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:10:20Z","timestamp":1793110220111,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"crossref","award":["YDZJ202201ZYTS594"],"award-info":[{"award-number":["YDZJ202201ZYTS594"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"DOI":"10.1186\/s13046-026-03726-2","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:55:01Z","timestamp":1778507701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nanovaccines with ferroptosis, necroptosis and STING-activation for synergistic immunotherapy"],"prefix":"10.1186","volume":"45","author":[{"given":"Jia-Rui","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Le","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Qiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4266-8941","authenticated-orcid":false,"given":"Deng-Ke","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"8","key":"3726_CR1","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.cell.2023.02.039","volume":"186","author":"RD Dagher","year":"2023","unstructured":"Dagher RD, Schwab SK, Brookens AD, Posey Jr. Advances in cancer immunotherapies. Cell. 2023;186(8):1814. https:\/\/doi.org\/10.1016\/j.cell.2023.02.039.","journal-title":"Cell"},{"issue":"6","key":"3726_CR2","doi-asserted-by":"publisher","first-page":"e2204932","DOI":"10.1002\/advs.202204932","volume":"10","author":"J Li","year":"2023","unstructured":"Li J, Lu W, Yang Y, Xiang R, Ling Y, Yu C, Zhou Y. Hybrid nanomaterials for cancer immunotherapy. Adv Sci. 2023;10(6):e2204932. https:\/\/doi.org\/10.1002\/advs.202204932.","journal-title":"Adv Sci"},{"issue":"1","key":"3726_CR3","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/s41467-018-03915-4","volume":"9","author":"T Wang","year":"2018","unstructured":"Wang T, Wang D, Yu H, Feng B, Zhou F, Zhang H, et al. A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors. Nat Commun. 2018;9(1):1532. https:\/\/doi.org\/10.1038\/s41467-018-03915-4.","journal-title":"Nat Commun"},{"issue":"6","key":"3726_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","volume":"21","author":"M Saxena","year":"2021","unstructured":"Saxena M, van der Burg SH, Melief CJM, Bhardwaj N. Therapeutic cancer vaccines. Nat Rev Cancer. 2021;21(6):360\u201378. https:\/\/doi.org\/10.1038\/s41568-021-00346-0.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3726_CR5","doi-asserted-by":"publisher","first-page":"e001369","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020;8(2):e001369. https:\/\/doi.org\/10.1136\/jitc-2020-001369.","journal-title":"J Immunother Cancer"},{"issue":"10","key":"3726_CR6","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/s41416-021-01294-0","volume":"124","author":"C Wang","year":"2021","unstructured":"Wang C, Haas MA, Yeo SK, Paul R, Yang F, Vallabhapurapu S, et al. Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis. Br J Cancer. 2021;124(10):1711\u201323. https:\/\/doi.org\/10.1038\/s41416-021-01294-0.","journal-title":"Br J Cancer"},{"key":"3726_CR7","doi-asserted-by":"publisher","first-page":"120638","DOI":"10.1016\/j.biomaterials.2020.120638","volume":"269","author":"L Xie","year":"2021","unstructured":"Xie L, Wang G, Sang W, Li J, Zhang Z, Li W, et al. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy. Biomaterials. 2021;269:120638. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120638.","journal-title":"Biomaterials"},{"issue":"9","key":"3726_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21(9):548\u201369. https:\/\/doi.org\/10.1038\/s41577-021-00524-z.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"3726_CR9","doi-asserted-by":"publisher","first-page":"e968434","DOI":"10.4161\/21624011.2014.968434","volume":"3","author":"I Adkins","year":"2015","unstructured":"Adkins I, Fucikova J, Garg AD, Agostinis P, \u0160p\u00ed\u0161ek R. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology. 2015;3(12):e968434. https:\/\/doi.org\/10.4161\/21624011.2014.968434.","journal-title":"Oncoimmunology"},{"key":"3726_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.actbio.2022.12.066","volume":"158","author":"Q Su","year":"2023","unstructured":"Su Q, Liu Z, Du R, Chen X, Chen L, Fu Z, et al. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy. Acta Biomater. 2023;158:510\u201324. https:\/\/doi.org\/10.1016\/j.actbio.2022.12.066.","journal-title":"Acta Biomater"},{"issue":"8","key":"3726_CR11","doi-asserted-by":"publisher","first-page":"e202115800","DOI":"10.1002\/anie.202115800","volume":"61","author":"X Su","year":"2022","unstructured":"Su X, Wang WJ, Cao Q, Zhang H, Liu B, Ling Y, et al. A carbonic anhydrase IX (CAIX)-anchored rhenium(I) photosensitizer evokes pyroptosis for enhanced anti-tumor immunity. Angew Chem Int Ed Engl. 2022;61(8):e202115800. https:\/\/doi.org\/10.1002\/anie.202115800.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"3726_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13(1):110. https:\/\/doi.org\/10.1186\/s13045-020-00946-7.","journal-title":"J Hematol Oncol"},{"key":"3726_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2021.04.013","volume":"334","author":"J Yang","year":"2021","unstructured":"Yang J, Ma S, Xu R, Wei Y, Zhang J, Zuo T, et al. Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy. J Control Release. 2021;334:21\u201333. https:\/\/doi.org\/10.1016\/j.jconrel.2021.04.013.","journal-title":"J Control Release"},{"key":"3726_CR14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.bioactmat.2025.06.034","volume":"52","author":"J Gao","year":"2025","unstructured":"Gao J, Ye T, Miao H, Liu M, Wen L, Tian Y, et al. Antibody-functionalized iron-based nanoplatform for ferroptosis-augmented targeted therapy of HER2-positive breast cancer. Bioact Mater. 2025;52:702\u201318. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.06.034.","journal-title":"Bioact Mater"},{"issue":"10","key":"3726_CR15","doi-asserted-by":"publisher","first-page":"e2104885","DOI":"10.1002\/advs.202104885","volume":"9","author":"C Chen","year":"2022","unstructured":"Chen C, Wang Z, Jia S, Zhang Y, Ji S, Zhao Z, et al. Evoking highly immunogenic ferroptosis aided by intramolecular motion-induced photo-hyperthermia for cancer therapy. Adv Sci. 2022;9(10):e2104885. https:\/\/doi.org\/10.1002\/advs.202104885.","journal-title":"Adv Sci"},{"issue":"7","key":"3726_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405\u201314. https:\/\/doi.org\/10.1038\/s41568-019-0149-1.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3726_CR17","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1021\/acsnano.2c01619","volume":"16","author":"L Yao","year":"2022","unstructured":"Yao L, Zhao MM, Luo QW, Zhang YC, Liu TT, Yang Z, et al. Carbon quantum dots-based nanozyme from coffee induces cancer cell ferroptosis to activate antitumor immunity. ACS Nano. 2022;16(6):9228\u201339. https:\/\/doi.org\/10.1021\/acsnano.2c01619.","journal-title":"ACS Nano"},{"issue":"7534","key":"3726_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"M Pasparakis","year":"2015","unstructured":"Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517(7534):311\u201320. https:\/\/doi.org\/10.1038\/nature14191.","journal-title":"Nature"},{"issue":"7516","key":"3726_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature13608","volume":"513","author":"M Dannappel","year":"2014","unstructured":"Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature. 2014;513(7516):90\u20134. https:\/\/doi.org\/10.1038\/nature13608.","journal-title":"Nature"},{"issue":"7338","key":"3726_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09857","volume":"471","author":"WJ Kaiser","year":"2011","unstructured":"Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature. 2011;471(7338):368\u201372. https:\/\/doi.org\/10.1038\/nature09857.","journal-title":"Nature"},{"issue":"5","key":"3726_CR21","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cell.2014.04.019","volume":"157","author":"JA Rickard","year":"2014","unstructured":"Rickard JA, O\u2019Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell. 2014;157(5):1175\u201388. https:\/\/doi.org\/10.1016\/j.cell.2014.04.019.","journal-title":"Cell"},{"issue":"1","key":"3726_CR22","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1038\/s41467-018-06985-6","volume":"9","author":"S Murai","year":"2018","unstructured":"Murai S, Yamaguchi Y, Shirasaki Y, Yamagishi M, Shindo R, Hildebrand JM, et al. A FRET biosensor for necroptosis uncovers two different modes of the release of DAMPs. Nat Commun. 2018;9(1):4457. https:\/\/doi.org\/10.1038\/s41467-018-06985-6.","journal-title":"Nat Commun"},{"key":"3726_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bioactmat.2025.10.012","volume":"56","author":"F Wang","year":"2025","unstructured":"Wang F, Fan J, Pan W, Liu M, Wang J, Wei X, et al. Probiotic-inspired hybrid nanovesicles for enhancing immune checkpoint therapy efficiency via tumor immune microenvironment modulation. Bioact Mater. 2025;56:197\u2013216. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.10.012.","journal-title":"Bioact Mater"},{"issue":"12","key":"3726_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol. 2021;21(12):785\u201397. https:\/\/doi.org\/10.1038\/s41577-021-00541-y.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"3726_CR25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/14760584.2021.1984890","volume":"20","author":"A Das","year":"2021","unstructured":"Das A, Ali N. Nanovaccine: an emerging strategy. Expert Rev Vaccines. 2021;20(10):1273\u201390. https:\/\/doi.org\/10.1080\/14760584.2021.1984890.","journal-title":"Expert Rev Vaccines"},{"key":"3726_CR26","doi-asserted-by":"publisher","unstructured":"Zhu J, Yuan A, Le Y, Chen X, Guo J, Liu J, et al. Yi-Qi-Jian-Pi-Xiao-Yu formula inhibits cisplatin-induced acute kidney injury through suppressing ferroptosis via STING-NCOA4-mediated ferritinophagy. Phytomedicine. 2024;156189. https:\/\/doi.org\/10.1016\/j.phymed.2024.156189.","DOI":"10.1016\/j.phymed.2024.156189"},{"issue":"7","key":"3726_CR27","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 2015;11(7):1018\u201330. https:\/\/doi.org\/10.1016\/j.celrep.2015.04.031.","journal-title":"Cell Rep"},{"key":"3726_CR28","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1084\/jem.20101159","volume":"208","author":"MB Fuertes","year":"2011","unstructured":"Fuertes MB, Kacha AK, Kline J, Woo SR, Kranz DM, Murphy KM, Gajewski TF. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8\u03b1\u2009+\u2009dendritic cells. J Exp Med. 2011;208:2005\u201316. https:\/\/doi.org\/10.1084\/jem.20101159.","journal-title":"J Exp Med"},{"issue":"50","key":"3726_CR29","doi-asserted-by":"publisher","first-page":"15408","DOI":"10.1073\/pnas.1512832112","volume":"112","author":"O Demaria","year":"2015","unstructured":"Demaria O, Gassart AD, Coso S, Gestermann N, Domizio JD, Flatz L, et al. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proc Natl Acad Sci U S A. 2015;112(50):15408\u201313. https:\/\/doi.org\/10.1073\/pnas.1512832112.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3726_CR30","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.2147\/IJN.S431221","volume":"18","author":"JR Du","year":"2023","unstructured":"Du JR, Teng DK, Wang Y, Wang Q, Lin YQ, Luo Q, et al. Endogenous H\u2082O\u2082 self-replenishment and sustainable cascades enhance the efficacy of sonodynamic therapy. Int J Nanomed. 2023;18:6667\u201387. https:\/\/doi.org\/10.2147\/IJN.S431221.","journal-title":"Int J Nanomed"},{"issue":"15","key":"3726_CR31","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.7150\/thno.81650","volume":"13","author":"W Feng","year":"2023","unstructured":"Feng W, Shi W, Cui Y, Xu J, Liu S, Gao H, et al. Fe (III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination. Theranostics. 2023;13(15):5266\u201389. https:\/\/doi.org\/10.7150\/thno.81650.","journal-title":"Theranostics"},{"issue":"2","key":"3726_CR32","doi-asserted-by":"publisher","first-page":"e2101926","DOI":"10.1002\/adhm.202101926","volume":"11","author":"W Feng","year":"2022","unstructured":"Feng W, Shi W, Liu S, Liu H, Liu Y, Ge P, Zhang H. Fe(III)-Shikonin supramolecular nanomedicine for combined therapy of tumor via ferroptosis and necroptosis. Adv Healthc Mater. 2022;11(2):e2101926. https:\/\/doi.org\/10.1002\/adhm.202101926.","journal-title":"Adv Healthc Mater"},{"issue":"33","key":"3726_CR33","doi-asserted-by":"publisher","first-page":"37540","DOI":"10.1021\/acsami.2c11130","volume":"14","author":"W Feng","year":"2022","unstructured":"Feng W, Shi W, Wang Z, Cui Y, Shao X, Liu S, et al. Enhancing tumor therapy of Fe (III)-Shikonin supramolecular nanomedicine via triple ferroptosis amplification. ACS Appl Mater Interfaces. 2022;14(33):37540\u201352. https:\/\/doi.org\/10.1021\/acsami.2c11130.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"3726_CR34","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1038\/s41467-020-19970-9","volume":"11","author":"K Hayashi","year":"2020","unstructured":"Hayashi K, Nikolos F, Lee YC, Jain A, Tsouko E, Gao H, et al. Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death. Nat Commun. 2020;11(1):6299. https:\/\/doi.org\/10.1038\/s41467-020-19970-9.","journal-title":"Nat Commun"},{"key":"3726_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol. 2013;31:51\u201372. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-100008.","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"3726_CR36","doi-asserted-by":"publisher","first-page":"e2105783","DOI":"10.1002\/adma.202105783","volume":"34","author":"J Yan","year":"2022","unstructured":"Yan J, Wang G, Xie L, Tian H, Li J, Li B, et al. Engineering radiosensitizer-based metal-phenolic networks potentiate STING pathway activation for advanced radiotherapy. Adv Mater. 2022;34(10):e2105783. https:\/\/doi.org\/10.1002\/adma.202105783.","journal-title":"Adv Mater"},{"issue":"1","key":"3726_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40824-023-00350-5","volume":"27","author":"J Zheng","year":"2023","unstructured":"Zheng J, Huang J, Zhang L, Wang M, Xu L, Dou X, et al. Drug-loaded microbubble delivery system to enhance PD-L1 blockade immunotherapy with remodeling immune microenvironment. Biomater Res. 2023;27(1):9. https:\/\/doi.org\/10.1186\/s40824-023-00350-5.","journal-title":"Biomater Res"},{"issue":"1","key":"3726_CR38","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41467-019-09760-3","volume":"10","author":"W Yue","year":"2019","unstructured":"Yue W, Chen L, Yu L, Zhou B, Yin H, Ren W, et al. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice. Nat Commun. 2019;10(1):2025. https:\/\/doi.org\/10.1038\/s41467-019-09760-3.","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"3726_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010.","journal-title":"Cell"},{"issue":"10","key":"3726_CR40","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1021\/jacs.2c12942","volume":"145","author":"P Zhu","year":"2023","unstructured":"Zhu P, Pu Y, Wang M, Wu W, Qin H, Shi J. MnOOH-catalyzed autoxidation of glutathione for reactive oxygen species production and nanocatalytic tumor innate immunotherapy. J Am Chem Soc. 2023;145(10):5803\u201315. https:\/\/doi.org\/10.1021\/jacs.2c12942.","journal-title":"J Am Chem Soc"},{"issue":"15","key":"3726_CR41","doi-asserted-by":"publisher","first-page":"14475","DOI":"10.1021\/acsnano.3c00901","volume":"17","author":"W Shi","year":"2023","unstructured":"Shi W, Feng W, Li S, Cui Y, Liu S, Jiang H, et al. Ferroptosis and necroptosis produced autologous tumor cell lysates co-delivering with combined immunoadjuvants as personalized in situ nanovaccines for antitumor immunity. ACS Nano. 2023;17(15):14475\u201393. https:\/\/doi.org\/10.1021\/acsnano.3c00901.","journal-title":"ACS Nano"},{"issue":"97","key":"3726_CR42","doi-asserted-by":"publisher","first-page":"eadm8185","DOI":"10.1126\/sciimmunol.adm8185","volume":"9","author":"YJ Crow","year":"2024","unstructured":"Crow YJ, Casanova JL. Human life within a narrow range: the lethal ups and downs of type I interferons. Sci Immunol. 2024;9(97):eadm8185. https:\/\/doi.org\/10.1126\/sciimmunol.adm8185.","journal-title":"Sci Immunol"},{"issue":"3","key":"3726_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41565-018-0342-5","volume":"14","author":"D Shae","year":"2019","unstructured":"Shae D, Becker KW, Christov P, Yun DS, Lytton-Jean AKR, Sevimli S, et al. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy. Nat Nanotechnol. 2019;14(3):269\u201378. https:\/\/doi.org\/10.1038\/s41565-018-0342-5.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"3726_CR44","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","volume":"49","author":"AJ Marcus","year":"2018","unstructured":"Marcus AJ, Mao A, Lensink-Vasan M, Wang L, Vance RE, Raulet DH. Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response. Immunity. 2018;49(4):754\u2013e7634. https:\/\/doi.org\/10.1016\/j.immuni.2018.09.016.","journal-title":"Immunity"},{"issue":"6","key":"3726_CR45","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.immuni.2014.05.003","volume":"40","author":"J Crouse","year":"2014","unstructured":"Crouse J, Bedenikovic G, Wiesel M, Ibberson M, Xenarios I, Laer DV, Kalinke U, et al. Type I interferons protect T cells from NK cell attack mediated by the activating receptor NCR1. Immunity. 2014;40(6):961\u201373. https:\/\/doi.org\/10.1016\/j.immuni.2014.05.003.","journal-title":"Immunity"},{"issue":"3","key":"3726_CR46","doi-asserted-by":"publisher","first-page":"e93490","DOI":"10.1007\/s00018-022-04219-z","volume":"79","author":"R Yu","year":"2022","unstructured":"Yu R, Zhu B, Chen D. Type I interferon-mediated tumor immunity and its role in immunotherapy. Cell Mol Life Sci. 2022;79(3):e93490. https:\/\/doi.org\/10.1007\/s00018-022-04219-z.","journal-title":"Cell Mol Life Sci"},{"issue":"21","key":"3726_CR47","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1158\/1078-0432.CCR-15-1362","volume":"21","author":"L Corrales","year":"2015","unstructured":"Corrales L, Gajewski TF. Molecular pathways: targeting the stimulator of interferon genes (STING) in the immunotherapy of cancer, Clin. Cancer Res. 2015;21(21):4774\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1362.","journal-title":"Cancer Res"},{"issue":"22","key":"3726_CR48","doi-asserted-by":"publisher","first-page":"e165616","DOI":"10.1172\/JCI165616","volume":"133","author":"Z Huang","year":"2023","unstructured":"Huang Z, Brodeur KE, Chen L, Du Y, Wobma H, Hsu EE, et al. Type I interferon signature and cycling lymphocytes in macrophage activation syndrome. J Clin Invest. 2023;133(22):e165616. https:\/\/doi.org\/10.1172\/JCI165616.","journal-title":"J Clin Invest"},{"issue":"10","key":"3726_CR49","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1084\/jem.20101158","volume":"208","author":"MS Diamond","year":"2011","unstructured":"Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med. 2011;208(10):1989\u20132003. https:\/\/doi.org\/10.1084\/jem.20101158.","journal-title":"J Exp Med"},{"issue":"4","key":"3726_CR50","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/med.22016","volume":"44","author":"X Tian","year":"2024","unstructured":"Tian X, Ai J, Tian X, Wei X. cGAS-STING pathway agonists are promising vaccine adjuvants. Med Res Rev. 2024;44(4):1768\u201399. https:\/\/doi.org\/10.1002\/med.22016.","journal-title":"Med Res Rev"},{"issue":"5","key":"3726_CR51","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"SR Woo","year":"2014","unstructured":"Woo SR, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MY, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014;41(5):830\u201342. https:\/\/doi.org\/10.1016\/j.immuni.2014.10.017.","journal-title":"Immunity"},{"issue":"4","key":"3726_CR52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.it.2015.02.003","volume":"36","author":"SR Woo","year":"2015","unstructured":"Woo SR, Corrales L, Gajewski TF. The STING pathway and the T cell-inflamed tumor microenvironment. Trends Immunol. 2015;36(4):250\u20136. https:\/\/doi.org\/10.1016\/j.it.2015.02.003.","journal-title":"Trends Immunol"},{"issue":"5","key":"3726_CR53","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1055\/a-1177-0530","volume":"41","author":"CF Dietrich","year":"2020","unstructured":"Dietrich CF, Nols\u00f8e CP, Barr RG, Berzigotti A, Burns PN, Cantisani V, et al. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2020 - WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med. 2020;41(5):562\u201385. https:\/\/doi.org\/10.1055\/a-1177-0530.","journal-title":"Ultraschall Med"},{"issue":"2","key":"3726_CR54","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723\u201350. https:\/\/doi.org\/10.1002\/hep.29913.","journal-title":"Hepatology"},{"issue":"1","key":"3726_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52\u201360. https:\/\/doi.org\/10.1055\/s-0030-1247132.","journal-title":"Semin Liver Dis"},{"issue":"5","key":"3726_CR56","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1007\/s00330-019-06649-z","volume":"30","author":"J Chen","year":"2020","unstructured":"Chen J, Zhu J, Zhang C, Song Y, Huang P. Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis. Eur Radiol. 2020;30(5):2871\u201380. https:\/\/doi.org\/10.1007\/s00330-019-06649-z.","journal-title":"Eur Radiol"},{"issue":"24","key":"3726_CR57","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.3390\/cancers15245743","volume":"15","author":"MQ Cheng","year":"2023","unstructured":"Cheng MQ, Huang H, Ruan SM, Xu P, Tong WJ, He DN. Complementary Role of CEUS and CT\/MR LI-RADS for Diagnosis of Recurrent HCC. Cancers. 2023;15(24):5743. https:\/\/doi.org\/10.3390\/cancers15245743.","journal-title":"Cancers"},{"issue":"3","key":"3726_CR58","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175\u201396. https:\/\/doi.org\/10.1038\/s41573-018-0006-z.","journal-title":"Nat Rev Drug Discov"},{"issue":"6382","key":"3726_CR59","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.aar7112","volume":"359","author":"U Sahin","year":"2018","unstructured":"Sahin U, T\u00fcreci \u00d6. Personalized vaccines for cancer immunotherapy. Science. 2018;359(6382):1355\u201360. https:\/\/doi.org\/10.1126\/science.aar7112.","journal-title":"Science"},{"issue":"4","key":"3726_CR60","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1158\/1078-0432.CCR-09-2175","volume":"16","author":"N Lassau","year":"2010","unstructured":"Lassau N, Koscielny S, Albiges L, Chami L, Benatsou B, Chebil M, et al. Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography, Clin. Cancer Res. 2010;16(4):1216\u201325. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2175.","journal-title":"Cancer Res"},{"issue":"2","key":"3726_CR61","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1055\/a-0586-1107","volume":"39","author":"PS Sidhu","year":"2018","unstructured":"Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications. Ultraschall Med. 2018;39(2):e2\u201344. https:\/\/doi.org\/10.1055\/a-0586-1107.","journal-title":"Ultraschall Med"},{"issue":"1","key":"3726_CR62","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","volume":"14","author":"Q Chen","year":"2019","unstructured":"Chen Q, Wang C, Zhang X, Chen G, Hu Q, Li H, et al. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. Nat Nanotechnol. 2019;14(1):89\u201397. https:\/\/doi.org\/10.1038\/s41565-018-0319-4.","journal-title":"Nat Nanotechnol"}],"updated-by":[{"DOI":"10.1186\/s13046-026-03770-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000}}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03726-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03726-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03726-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:51:45Z","timestamp":1782971505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03726-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3726"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03726-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the authors spotted errors in the body of the article and the contents of Figure 4 incorrectly presented in Figure 2 causing duplicate Figure 2.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-026-03770-y","URL":"https:\/\/doi.org\/10.1186\/s13046-026-03770-y","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were performed at Changchun Wish Detection Technology Service Co., Ltd. Ethics approval (approval no. 20231027-01) was provided by Changchun Wish Detection Technology Service Co., Ltd., and our laboratory animal welfare protocol was in accordance with both GB\/T 35892\u2009\u2212\u20092018: Guidelines for the Ethical Review of Laboratory Animal Welfare and the Guide for the Care and Use of Laboratory Animals: Eighth Edition. The company was chosen because Changchun Wish Detection Technology Service Co., Ltd. signed a cooperation agreement with the Bethune Medical Science Center of Jilin University to ensure the smooth conduct of our animal experiments, and our unit, the China\u2013Japan Union Hospital of Jilin University, is affiliated to the Bethune Medical Science Center of Jilin University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}